Jones et al. described p210-ALL as a disease with a CML background, which is characterized by higher BCR-ABL1 transcript levels and more frequent persistent BCR-ABL1 expression [20]. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.